Abstracts & Presentations
International Conferences
2016 International Conferences
(By conference, by month, by author)
IDWeek 2016, New Orleans, Louisiana, October 2016
Boatman J et al. Risk factors for low immune recovery among participants
with CD4 counts > 500 cells/?L in the immediate antiretrovrial treatment
(ART) group in Strategic Timing of AntiRetroviral Treatment (START) Trial
who achieved viral suppression --
Abstract
| Poster
Options IX for the Control of Influenza, Chicago, Illinois, August
2016
Dwyer D et al, Comparison of the outcomes of individuals with
medically-attended influenza A and B infections enrolled in two
international cohort studies (INSIGHT FLU002 and FLU003) over a six-year
period: 2009-2015 --
Abstract
| Slides
Simonsen L et al. A role for the INSIGHT clinical research network in rapid
assessment of key clinical and epidemiological characteristics of a future
pandemic -- Abstract
| Slides
AIDS 2016, Durban, South Africa, July 2016
Arenas-Pinto A et al, Increased risk of suicidal behaviour with use of
efavirenz: results from the START trial --
Abstract
| Slides
Babiker A et al, The role of plasma HIV RNA and T cell subset counts/percent
and ratio in explaining the benefit of immediate antiretroviral therapy (ART)
initiation in HIV+ individuals with high CD4+ counts --
Abstract
| Poster
Matthews G (Rockstroh J, presenting) et al, Non-invasive serum markers
suggest benefit for early ART initiation on liver fibrosis progression
within the START study --
Abstract
| Poster
Mocroft A et al, Deferred antiretroviral therapy is associated with lower
estimated glomerular filtration rate in HIV-positive individuals with high
CD4 counts --
Abstract
| Poster
Molina J-M et al, Who benefited most from immediate treatment in START? A
subgroup analysis --
Abstract
| Slides
Rodger A et al, Assessment of the impact of early ART on sexual behaviour
in INSIGHT strategic timing of antiretroviral treatment (START) trial --
Abstract
| Poster
ISPOR 21st Annual International Meeting, Washington DC, May 2016
Powers III JH et al, Evaluation of the performance properties of the
influenza patient-reported outcomes instrument (FLU-PRO) --
Abstract
| Poster
Conference on Retroviruses and Opportunistic Infections (CROI) 2016, Boston,
Massachusetts, February 2016
Baker J et al, Changes in CVD risk factors with early and deferred ART in the
START trial --
Abstract
| Poster
Baker J et al, Early antiretroviral therapy does not improve vascular
function: a START substudy --
Abstract
| Slides
| Video
Borges A et al, Immediate ART initiation reduces risk of infection-related
cancer in HIV infection --
Abstract
| Slides
| Audio
Lifson A et al, Increased quality of life with immediate ART initiation:
results from the START trial --
Abstract
| Poster
O'Connor G et al, Effect of immediate ART on risk of severe bacterial
infections: the START trial --
Abstract
| Poster
